The $55/share cash offer provides a clear take-out price with a ~54% premium. Monitor the go-shop process through August 27 for potential competing bids. The deal is expected to close in Q4 2026, subject to shareholder and regulatory approvals. The separate material weaknesses and ESPP issue are unlikely to be deal-breakers given the structure and size of the transaction, but could cause delays. The stock should trade at a slight discount to the offer price reflecting deal risk and time value.
Price Chart
Executive Summary
CBIZ has entered into a definitive merger agreement to be acquired by Grant Thornton Advisors LLC for $55.00 per share in cash, representing an enterprise value of $5 billion and a ~54% premium to the 30-day VWAP. The transaction is supported by New Mountain Capital, which is providing incremental equity financing, and is expected to close in Q4 2026. Separately, CBIZ disclosed material weaknesses in internal control over financial reporting related to ESPP share administration and goodwill reassignment, along with a voluntary rescission offer for up to 481,049 shares issued in excess of ESPP authorization, with potential aggregate payments of up to $20.2 million.
Key Facts
- Grant Thornton Advisors to acquire CBIZ for $55.00 per share in cash, enterprise value of $5 billion
- ~54% premium to CBIZ's 30-day volume-weighted average share price
- New Mountain Capital providing incremental equity investment to support the transaction
- CBIZ Benefits and Insurance Services segment to be separated into a stand-alone entity backed by New Mountain Capital
- Go-shop period runs through August 27, 2026; CBIZ may solicit superior proposals
- Company termination fee of $107.5 million (or $49.6 million if termination occurs during go-shop period with an Excluded Party)
- Parent termination fee of $198.4 million
- Financing of $5.2 billion committed via equity and debt commitment letters from New Mountain Capital and third-party sources
- CBIZ discovered it inadvertently purchased up to 481,049 shares in excess of ESPP authorization from October 2023 to April 2026
- Voluntary rescission offer to be made in Q3 2026; potential aggregate payments up to $20.2 million
- Two material weaknesses identified: ESPP share administration and goodwill reassignment among reporting units
- Prior internal control over financial reporting conclusions as of December 31, 2025 should no longer be relied upon
- Immaterial revisions to Q1 2026 financial statements: net income reduced by $8.8 million, EPS reduced by $0.14 per share
Financial Impact
Shareholders to receive $55.00 per share in cash, representing a ~54% premium. Enterprise value of $5 billion. ESPP rescission offer could require up to $20.2 million in aggregate payments. Material weakness remediation costs not quantified.
Risk Factors
- Shareholder approval required; risk of rejection or competing superior proposal during go-shop period
- HSR and other regulatory approvals needed; potential delays or conditions
- Material weaknesses in internal control add regulatory and reputational risk
- ESPP rescission offer could result in up to $20.2 million in cash outflows
- Financing committed but subject to customary closing conditions; market disruption could impact availability
- Integration risk post-merger; CBIZ Benefits and Insurance segment to be separated as independent entity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (CBZ) — Batch item 1 | 0001193125-26-322277 |
| Document: 0001193125-26-322277-index-headers.html | 0001193125-26-322239 |
| Document: 0001193125-26-322277-index.html | 0001193125-26-322225 |
| Document: 0001193125-26-322277.txt | 0001193125-26-322277 |
| 8-K Filing (CBZ) — Batch item 5 | 0001193125-26-322239 |
| 8-K Filing (CBZ) — Batch item 6 | 0001193125-26-322225 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $54.89 $54.94 | ▲ +0.09% | ▲ +0.61% | $54.85 (−0.07%) |
Oct 19, 2026 7d ago | 8-K | $54.78 $54.89 | ▲ +0.20% | ▼ −0.13% | $54.85 (+0.13%) |
Oct 19, 2026 7d ago | Press Release | $54.78 $54.89 | ▲ +0.20% | ▼ −0.13% | $54.85 (+0.13%) |
Aug 6, 2026 11w ago | S-3ASR | $54.49 $54.50 | ▲ +0.02% | ▼ −0.59% | $54.85 (+0.66%) |
Jul 31, 2026 12w ago | DEFA14A | $55.08 $55.07 | ▼ −0.02% | ▼ −1.44% | $54.85 (−0.42%) |
Jul 29, 2026 12w ago | DEFA14A | $55.25 $55.08 | ▼ −0.31% | ▼ −1.01% | $54.85 (−0.72%) |
Jul 29, 2026 12w ago | DEFA14A / 8-K | $54.90 $55.25 | ▲ +0.64% | ▼ −1.04% | $54.85 (−0.09%) |
Jul 29, 2026 12w ago | 8-K | $54.90 $55.25 | ▲ +0.64% | ▼ −1.04% | $54.85 (−0.09%) |
Apr 15, 2026 27w ago | Press Release | $30.35 | awaiting T+1 | — | $54.85 (+80.72%) |
Apr 14, 2026 27w ago | Press Release | $29.09 $30.35 | ▲ +4.33% | ▲ +3.56% | $54.85 (+88.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers